Logo image of HUDA

HUDSON ACQUISITION I CORP (HUDA) Stock Fundamental Analysis

NASDAQ:HUDA - Nasdaq - US44364H1005 - Common Stock - Currency: USD

12.56  -0.5 (-3.85%)

Fundamental Rating

0

HUDA gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. HUDA has a bad profitability rating. Also its financial health evaluation is rather negative. HUDA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HUDA has reported negative net income.
HUDA had a negative operating cash flow in the past year.
HUDA Yearly Net Income VS EBIT VS OCF VS FCFHUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 -100K -200K -300K -400K -500K

1.2 Ratios

Industry RankSector Rank
ROA 0.08%
ROE 0.1%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HUDA Yearly ROA, ROE, ROICHUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 -1 -2 -3 -4 -5

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HUDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HUDA Yearly Profit, Operating, Gross MarginsHUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, HUDA has more shares outstanding
There is no outstanding debt for HUDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HUDA Yearly Shares OutstandingHUDA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2M 4M 6M 8M
HUDA Yearly Total Debt VS Total AssetsHUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.18 indicates that HUDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
HUDA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACCN/A
WACCN/A
HUDA Yearly LT Debt VS Equity VS FCFHUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M 60M

2.3 Liquidity

HUDA has a Current Ratio of 0.06. This is a bad value and indicates that HUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
HUDA has a Quick Ratio of 0.06. This is a bad value and indicates that HUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
HUDA Yearly Current Assets VS Current LiabilitesHUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 100K 200K 300K 400K

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HUDA Yearly Revenue VS EstimatesHUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022
HUDA Yearly EPS VS EstimatesHUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUDA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HUDA Price Earnings VS Forward Price EarningsHUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HUDA Per share dataHUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HUDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUDSON ACQUISITION I CORP

NASDAQ:HUDA (7/22/2024, 8:00:02 PM)

12.56

-0.5 (-3.85%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.86%
Inst Owner Change-58.33%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.86M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0
BVpS11.36
TBVpS11.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 2.18
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2087.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-269.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-269.25%
OCF growth 3YN/A
OCF growth 5YN/A